Earnings Call · Q4 FY2022·2022-08-11

Q4 22EPS +2.05%·Rev n/aQ3 22EPS -8.33%·Rev n/aQ2 22EPS -3.29%·Rev n/aQ1 22EPS +11.85%·Rev n/a⚠ consensus missing

RESMED INC RMD

Amy Wakeham — Vice President, Investor Relations

Michael Farrell — Chief Executive Officer

Brett Sandercock — Chief Financial Officer

−0.4%1d on move date−2.0% vs SPY3d−2.0%5d−1.8%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more RMD calls or request research access.

More RMD calls Browse calls Request research access